282 related articles for article (PubMed ID: 31376305)
21. Development of robustness evaluation strategies for enabling statistically consistent reporting.
Sterpin E; Rivas ST; Van den Heuvel F; George B; Lee JA; Souris K
Phys Med Biol; 2021 Feb; 66(4):045002. PubMed ID: 33296875
[TBL] [Abstract][Full Text] [Related]
22. A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer.
Kurz C; Landry G; Resch AF; Dedes G; Kamp F; Ganswindt U; Belka C; Raaymakers BW; Parodi K
Phys Med Biol; 2017 Oct; 62(21):8470-8482. PubMed ID: 29047455
[TBL] [Abstract][Full Text] [Related]
23. Proton radiography and fluoroscopy of lung tumors: a Monte Carlo study using patient-specific 4DCT phantoms.
Han B; Xu XG; Chen GT
Med Phys; 2011 Apr; 38(4):1903-11. PubMed ID: 21626923
[TBL] [Abstract][Full Text] [Related]
24. Investigation of four-dimensional (4D) Monte Carlo dose calculation in real-time tumor tracking stereotatic body radiotherapy for lung cancers.
Chan MK; Kwong DL; Ng SC; Tam EK; Tong AS
Med Phys; 2012 Sep; 39(9):5479-87. PubMed ID: 22957615
[TBL] [Abstract][Full Text] [Related]
25. Incorporating the effect of fractionation in the evaluation of proton plan robustness to setup errors.
Lowe M; Albertini F; Aitkenhead A; Lomax AJ; MacKay RI
Phys Med Biol; 2016 Jan; 61(1):413-29. PubMed ID: 26675133
[TBL] [Abstract][Full Text] [Related]
26. The relative accuracy of 4D dose accumulation for lung radiotherapy using rigid dose projection versus dose recalculation on every breathing phase.
Valdes G; Lee C; Tenn S; Lee P; Robinson C; Iwamoto K; Low D; Lamb JM
Med Phys; 2017 Mar; 44(3):1120-1127. PubMed ID: 28019649
[TBL] [Abstract][Full Text] [Related]
27. Assessment of range uncertainty in lung-like tissue using a porcine lung phantom and proton radiography.
Meijers A; Seller OC; Free J; Bondesson D; Seller Oria C; Rabe M; Parodi K; Landry G; Langendijk JA; Both S; Kurz C; Knopf AC
Phys Med Biol; 2020 Jul; 65(15):155014. PubMed ID: 32392543
[TBL] [Abstract][Full Text] [Related]
28. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
Stützer K; Lin A; Kirk M; Lin L
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
[TBL] [Abstract][Full Text] [Related]
29. Limitations of phase-sorting based pencil beam scanned 4D proton dose calculations under irregular motion.
Duetschler A; Prendi J; Safai S; Weber DC; Lomax AJ; Zhang Y
Phys Med Biol; 2022 Dec; 68(1):. PubMed ID: 36571234
[No Abstract] [Full Text] [Related]
30. Uncertainty reduction in intensity modulated proton therapy by inverse Monte Carlo treatment planning.
Morávek Z; Rickhey M; Hartmann M; Bogner L
Phys Med Biol; 2009 Aug; 54(15):4803-19. PubMed ID: 19622848
[TBL] [Abstract][Full Text] [Related]
31. Investigating volumetric repainting to mitigate interplay effect on 4D robustly optimized lung cancer plans in pencil beam scanning proton therapy.
Rana S; Rosenfeld AB
J Appl Clin Med Phys; 2021 Mar; 22(3):107-118. PubMed ID: 33599391
[TBL] [Abstract][Full Text] [Related]
32. A novel and individualized robust optimization method using normalized dose interval volume constraints (NDIVC) for intensity-modulated proton radiotherapy.
Shan J; Sio TT; Liu C; Schild SE; Bues M; Liu W
Med Phys; 2019 Jan; 46(1):382-393. PubMed ID: 30387870
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive 4D robustness evaluation for pencil beam scanned proton plans.
Ribeiro CO; Meijers A; Korevaar EW; Muijs CT; Both S; Langendijk JA; Knopf A
Radiother Oncol; 2019 Jul; 136():185-189. PubMed ID: 31015123
[TBL] [Abstract][Full Text] [Related]
34. Toward a new treatment planning approach accounting for in vivo proton range verification.
Tian L; Landry G; Dedes G; Kamp F; Pinto M; Niepel K; Belka C; Parodi K
Phys Med Biol; 2018 Oct; 63(21):215025. PubMed ID: 30375361
[TBL] [Abstract][Full Text] [Related]
35. A spot-specific range uncertainty framework for robust optimization of proton therapy treatments.
Cohilis M; Souris K; Buti G; Chang CW; Lin L; Lee JA; Sterpin E
Med Phys; 2023 Oct; 50(10):6554-6568. PubMed ID: 37676906
[TBL] [Abstract][Full Text] [Related]
36. Experimental validation of 4D log file-based proton dose reconstruction for interplay assessment considering amplitude-sorted 4DCTs.
Spautz S; Jakobi A; Meijers A; Peters N; Löck S; Knopf AC; Troost EGC; Richter C; Stützer K
Med Phys; 2022 Jun; 49(6):3538-3549. PubMed ID: 35342943
[TBL] [Abstract][Full Text] [Related]
37. Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.
Botas P; Grassberger C; Sharp G; Paganetti H
Phys Med Biol; 2018 Jan; 63(3):035023. PubMed ID: 29219119
[TBL] [Abstract][Full Text] [Related]
38. Range uncertainties in proton therapy and the role of Monte Carlo simulations.
Paganetti H
Phys Med Biol; 2012 Jun; 57(11):R99-117. PubMed ID: 22571913
[TBL] [Abstract][Full Text] [Related]
39. Reporting and analyzing statistical uncertainties in Monte Carlo-based treatment planning.
Chetty IJ; Rosu M; Kessler ML; Fraass BA; Ten Haken RK; Kong FM; McShan DL
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1249-59. PubMed ID: 16798417
[TBL] [Abstract][Full Text] [Related]
40. Simulation of dosimetric consequences of 4D-CT-based motion margin estimation for proton radiotherapy using patient tumor motion data.
Koybasi O; Mishra P; St James S; Lewis JH; Seco J
Phys Med Biol; 2014 Feb; 59(4):853-67. PubMed ID: 24487573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
